TrademarkOpen
Search / United States / 97028340

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Service Mark

KEYSTONE

Registered
Used for: providing medical research information in the field of clinical trials in relation to hemophilia and gene therapy…
Show more

providing medical research information in the field of clinical trials in relation to hemophilia and gene therapy; medical research in the field of hemophilia and gene therapy

Class 42 – Technology & SaaS

Status timeline

  1. 18 Sep 2021
    Application filed
    New Application Entered
  2. 18 Jun 2022
    Assigned to an examining attorney
    Assigned To Examiner
  3. 27 Jun 2022
    Approved for publication
    Approved For Pub - Principal Register
  4. 27 Jun 2022
    Office action issued
    Non-Final Action Written
  5. 6 Jul 2022
    Response to office action filed
    Teas Response To Office Action Received
  6. 15 Jul 2022
    Approved for publication
    Approved For Pub - Principal Register
  7. 23 Aug 2022
    Published for opposition
    Published For Opposition
  8. 18 Oct 2022
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  9. 1 Mar 2023
    Statement of use filed
    Teas Statement Of Use Received
  10. 14 Mar 2023
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  11. 9 Apr 2023
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  12. 11 Apr 2023
    Statement of use accepted
    Notice Of Acceptance Of Statement Of Use E-Mailed
  13. 16 May 2023
    Registered on the Principal Register
    Registered-Principal Register
All 29 events
2023-05-16Registered-Principal Register
2023-05-16Notice Of Registration Confirmation Emailed
2023-04-11Notice Of Acceptance Of Statement Of Use E-Mailed
2023-04-09Allowed Principal Register - Sou Accepted
2023-03-15Notice Of Approval Of Extension Request E-Mailed
2023-03-14Case Assigned To Intent To Use Paralegal
2023-03-14Sou Extension 1 Granted
2023-03-14Statement Of Use Processing Complete
2023-03-01Teas Statement Of Use Received
2023-03-01Sou Teas Extension Received
2023-03-01Sou Extension 1 Filed
2023-03-01Use Amendment Filed
2022-10-18Noa Mailed - Sou Required From Applicant
2022-08-23Published For Opposition
2022-08-23Official Gazette Publication Confirmation E-Mailed
2022-08-03Notification Of Notice Of Publication E-Mailed
2022-07-15Approved For Pub - Principal Register
2022-07-06Teas Response To Office Action Received
2022-07-06Correspondence Received In Law Office
2022-07-06Teas/Email Correspondence Entered
2022-06-27Approved For Pub - Principal Register
2022-06-27Previous Allowance Count Withdrawn
2022-06-27Non-Final Action Written
2022-06-27Non-Final Action E-Mailed
2022-06-27Notification Of Non-Final Action E-Mailed
2022-06-18Assigned To Examiner
2021-10-22Notice Of Design Search Code E-Mailed
2021-10-21New Application Office Supplied Data Entered
2021-09-18New Application Entered

Goods & services by class

Class 42 Technology & SaaS

providing medical research information in the field of clinical trials in relation to hemophilia and gene therapy; medical research in the field of hemophilia and gene therapy

First use anywhere 9 Feb 2023 · First use in commerce 9 Feb 2023

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 8 Jul 2023; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.